Answers are grounded in this paper and cite their sources.
Nanopore sequencing has emerged as a transformative technology, offering unprecedented speed, ultra-long reads, and portability at a comparatively low cost. These attributes are fundamentally reshaping clinical diagnostics and personalized medicine. This review synthesizes the technological advancements driving nanopore sequencing and elucidates its pivotal applications in time-sensitive areas such as HLA matching in transplantation, infectious disease management, pharmacogenomics, and oncology. Nanopore sequencing also enables comprehensive characterization of immune-related genomic variation including HLA, KIR, LILR, Fc receptor loci, immune regulatory variants and epigenetic features. We explore the profound impact of real-time genomics on patient care, emphasizing the potential for point-of-care testing, the acceleration of clinical decision support, and the realization of precision medicine.
No takes yet. Share an insight, caveat, or question.
Grasedieck et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: